🇺🇸 The U.S. Cell and Gene Therapy Third-Party Logi..

6 hrs

🇺🇸 The U.S. Cell and Gene Therapy Third-Party Logistics (3PL) Market is projected to grow from US$2.61 billion in 2024 to US$5.88 billion by 2033, expanding at a strong CAGR of 9.46% 📈

Growing adoption of advanced cell and gene therapies across the healthcare sector

🔗 Read full report: 👉 https://www.renub.com/us-cell-....gene-therapy-third-p

📊 #celltherapy #genetherapy #biopharmalogistics #coldchain #healthcareinnovation #pharmasupplychain #3pl #biotech #ustherapymarket #renubresearch

U.S. Cell & Gene Therapy 3PL Market Outlook 2025

U.S. Cell and Gene Therapy Third-Party Logistics Market is expected to reach US$ 5.88 billion by 2033 from US$ 2.61 billion in 2024, CAGR of 9.46% from 2025 to 2033.

Like

Comment

Share